Oscar Arrieta-Garcia - Publications

Correction: Prognostic impact of nectin-like molecule-5 (CD155) expression in non-small cell lung cancer.

Journal: Journal of translational medicine

Published: July 03, 2025

In response to "On the Hispanic paradox in lung cancer".

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 14, 2024

Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy.

Journal: Cancer metastasis reviews

Published: May 15, 2024

Facing an un-met need in lung cancer screening: The never smokers.

Journal: Critical reviews in oncology/hematology

Published: April 01, 2024

Prognostic impact of nectin-like molecule-5 (CD155) expression in non-small cell lung cancer.

Journal: Journal of translational medicine

Published: March 25, 2024

Impact of KRASG12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 26, 2023

Somatic and germline ATM variants in non-small-cell lung cancer: Therapeutic implications.

Journal: Critical reviews in oncology/hematology

Published: May 15, 2023

Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical Trial.

Journal: International journal of radiation oncology, biology, physics

Published: July 26, 2021

Clinical and pathological characteristics associated with the presence of the IS6110 Mycobacterim tuberculosis transposon in neoplastic cells from non-small cell lung cancer patients.

Journal: Scientific reports

Published: June 05, 2021

Prognosis of breast cancer diagnosed during pregnancy and early postpartum according to immunohistochemical subtype: A matched case-control study.

Journal: Breast cancer research and treatment

Published: January 04, 2021

Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial).

Journal: International journal of radiation oncology, biology, physics

Published: October 13, 2020

Prophylactic Cranial Irradiation in Patients With High-Risk Metastatic Non-Small Cell Lung Cancer: Quality of Life and Neurocognitive Analysis of a Randomized Phase II Study.

Journal: International journal of radiation oncology, biology, physics

Published: October 13, 2020